Literature DB >> 21543999

Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure.

Annika Kurvinen1, Markku J Nissinen, Helena Gylling, Tatu A Miettinen, Hanna Lampela, Antti I Koivusalo, Risto J Rintala, Mikko P Pakarinen.   

Abstract

BACKGROUND AND
OBJECTIVE: Plant sterols (PS) in parenteral nutrition (PN) may contribute to intestinal failure-associated liver disease. We investigated interrelations between serum PS, liver function and histology, cholesterol metabolism, and characteristics of PN. PATIENTS AND METHODS: Eleven patients with intestinal failure (mean age 6.3 years) receiving long-term PN were studied prospectively (mean 254 days) and underwent repeated measurements of serum lipids, noncholesterol sterols, including PS, and liver enzymes. PS contents of PN were analyzed. Liver biopsy was obtained in 8 patients. Twenty healthy children (mean age 5.7 years) served as controls.
RESULTS: Median percentage of parenteral energy of total daily energy (PN%) was 48%, including 0.9 g · kg(-1) · day(-1) of lipids. Respective amounts of PN sitosterol, campesterol, avenasterol, and stigmasterol were 683, 71, 57, and 45 μg · kg(-1) · day(-1). Median serum concentrations of sitosterol (48 vs 7.5 μmol/L, P < 0.001), avenasterol (2.9 vs 1.9, P < 0.01), stigmasterol (1.9 vs 1.2, P < 0.005), but not that of campesterol (9.8 vs 12, P = 0.22), were increased among patients in relation to controls, and correlated with PN% (r = 0.81-0.88, P < 0.005), but not with PN fat. Serum cholesterol precursors were higher in patients than in controls. Serum liver enzymes remained close to normal range. Glutamyl transferase correlated with serum PS (r = 0.61-0.62, P < 0.05). Liver fibrosis in 5 patients reflected increased serum PS (r = 0.55-0.60, P = 0.16-0.12).
CONCLUSIONS: Serum PS moderately increase during olive oil-based PN, and correlate positively with PN% and glutamyl transferase. Despite well-preserved liver function, histology often revealed significant liver damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543999     DOI: 10.1097/MPG.0b013e3182212130

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  14 in total

Review 1.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

2.  Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.

Authors:  Kenneth Ng; Barbara Stoll; Shaji Chacko; Miguel Saenz de Pipaon; Charlotte Lauridsen; Matthew Gray; E James Squires; Juan Marini; Irving J Zamora; Oluyinka O Olutoye; Douglas G Burrin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-01-16       Impact factor: 4.016

Review 3.  Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.

Authors:  Douglas G Burrin; Ken Ng; Barbara Stoll; Miguel Sáenz De Pipaón
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

4.  Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Padade M Vue; Wujuan Zhang; Kenneth D R Setchell; Saul J Karpen; Ronald J Sokol
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

Review 5.  Complications associated with parenteral nutrition in the neonate.

Authors:  Kara L Calkins; Robert S Venick; Sherin U Devaskar
Journal:  Clin Perinatol       Date:  2014-06       Impact factor: 3.430

Review 6.  Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children.

Authors:  Prathima Nandivada; Gillian L Fell; Kathleen M Gura; Mark Puder
Journal:  Am J Clin Nutr       Date:  2016-01-20       Impact factor: 7.045

7.  New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs.

Authors:  Hester Vlaardingerbroek; Kenneth Ng; Barbara Stoll; Nancy Benight; Shaji Chacko; Leo A J Kluijtmans; Wim Kulik; E James Squires; Oluyinka Olutoye; Deborah Schady; Milton L Finegold; Johannes B van Goudoever; Douglas G Burrin
Journal:  J Lipid Res       Date:  2014-01-29       Impact factor: 5.922

8.  The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.

Authors:  Prathima Nandivada; Melissa I Chang; Alexis K Potemkin; Sarah J Carlson; Eileen Cowan; Alison A Oʼloughlin; Paul D Mitchell; Kathleen M Gura; Mark Puder
Journal:  Ann Surg       Date:  2015-01       Impact factor: 12.969

9.  Depletion and enrichment of phytosterols in soybean oil lipid emulsions directly associate with serum markers of cholestasis in preterm parenteral nutrition-fed pigs.

Authors:  Greg Guthrie; Barbara Stoll; Shaji Chacko; Mahmoud Mohammad; Candace Style; Mariatu Verla; Oluyinka Olutoye; Deborah Schady; Charlotte Lauridsen; Nick Tataryn; Douglas Burrin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-04-30       Impact factor: 4.016

10.  NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.

Authors:  Swati Ghosh; Michael W Devereaux; Aimee L Anderson; Sarah Gehrke; Julie A Reisz; Angelo D'Alessandro; David J Orlicky; Mark Lovell; Karim C El Kasmi; Colin T Shearn; Ronald J Sokol
Journal:  Hepatology       Date:  2021-08-27       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.